Nordmark Arzneimittel GmbH & Co. KG - Product Pipeline Review - 2014

Published: Jan, 2014 | Pages: 29 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Summary

Global Market Direct's pharmaceuticals report, "Nordmark Arzneimittel GmbH & Co. KG - Product Pipeline Review - 2014" provides data on the Nordmark Arzneimittel GmbH & Co. KG's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Nordmark Arzneimittel GmbH & Co. KG's corporate website, SEC filings, investor presentations and featured press releases, both from Nordmark Arzneimittel GmbH & Co. KG and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- Nordmark Arzneimittel GmbH & Co. KG - Brief Nordmark Arzneimittel GmbH & Co. KG overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Nordmark Arzneimittel GmbH & Co. KG human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Nordmark Arzneimittel GmbH & Co. KG with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Nordmark Arzneimittel GmbH & Co. KG's pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Nordmark Arzneimittel GmbH & Co. KG's strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Nordmark Arzneimittel GmbH & Co. KG in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Nordmark Arzneimittel GmbH & Co. KG's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Nordmark Arzneimittel GmbH & Co. KG.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Nordmark Arzneimittel GmbH & Co. KG and identify potential opportunities in those areas.

 Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Nordmark Arzneimittel GmbH & Co. KG Snapshot 5
Nordmark Arzneimittel GmbH & Co. KG Overview 5
Key Information 5
Key Facts 5
Nordmark Arzneimittel GmbH & Co. KG - Research and Development Overview 6
Key Therapeutic Areas 6
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products Glance 10
Nordmark Arzneimittel GmbH & Co. KG - Clinical Stage Pipeline Products 10
Phase I Products/Combination Treatment Modalities 10
Nordmark Arzneimittel GmbH & Co. KG - Early Stage Pipeline Products 11
Preclinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Nordmark Arzneimittel GmbH & Co. KG - Unknown Stage Pipeline Products 13
Unknown Products/Combination Treatment Modalities 13
Nordmark Arzneimittel GmbH & Co. KG - Drug Profiles 14
ancrod 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
burlulipase 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Project Interleukin-2 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
Project BALI 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Project Nordmark Collagenase 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Analysis 20
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products by Therapeutic Class 20
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products by Target 22
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products by Route of Administration 23
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products by Molecule Type 24
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products by Mechanism of Action 25
Nordmark Arzneimittel GmbH & Co. KG - Discontinued Pipeline Products 26
Discontinued Pipeline Product Profiles 26
ancrod 26
Nordmark Arzneimittel GmbH & Co. KG - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 29
Disclaimer 29

List of Tables
Nordmark Arzneimittel GmbH & Co. KG, Key Information 5
Nordmark Arzneimittel GmbH & Co. KG, Key Facts 5
Nordmark Arzneimittel GmbH & Co. KG - Pipeline by Indication, 2014 7
Nordmark Arzneimittel GmbH & Co. KG - Pipeline by Stage of Development, 2014 8
Nordmark Arzneimittel GmbH & Co. KG - Monotherapy Products in Pipeline, 2014 9
Nordmark Arzneimittel GmbH & Co. KG - Phase I, 2014 10
Nordmark Arzneimittel GmbH & Co. KG - Preclinical, 2014 11
Nordmark Arzneimittel GmbH & Co. KG - Discovery, 2014 12
Nordmark Arzneimittel GmbH & Co. KG - Unknown, 2014 13
Nordmark Arzneimittel GmbH & Co. KG - Pipeline by Therapeutic Class, 2014 21
Nordmark Arzneimittel GmbH & Co. KG - Pipeline by Target, 2014 22
Nordmark Arzneimittel GmbH & Co. KG - Pipeline by Route of Administration, 2014 23
Nordmark Arzneimittel GmbH & Co. KG - Pipeline by Molecule Type, 2014 24
Nordmark Arzneimittel GmbH & Co. KG - Pipeline Products by Mechanism of Action, 2014 25
Nordmark Arzneimittel GmbH & Co. KG - Discontinued Pipeline Products, 2014 26